Skip to main content
. 2003 Feb;185(3):809–822. doi: 10.1128/JB.185.3.809-822.2003

TABLE 5.

In vivo assays of traM cross-functionalitya

TraM Plasmid β-Galactosidase sp act (Miller units)b with:
No inducer AAIc IPTG (1 mM) IPTG + AAI
pBBR1-MCS5 (vector)d <5 571 <5 551
pGB200 (Ti traM) <5 528 <5 32
pCF424 (NGR234 traM) <5 578 <5 612
a

All assays were performed with A. tumefaciens NTL4 harboring pCF218 (PtetR-traR) and pCF372 (PtraI-lacZ).

b

Results are averages from assays in triplicate.

c

With 0.05% (vol/vol) cell-free supernatant of the AAI overproducer A. tumefaciens KYC6(pCF218), having bioactivity equivalent to 0.4 μM synthetic 3-oxo-C8-HSL.

d

Both traM expression plasmids are derivatives of pBBR1-MCS5.